We further found that cognitive reserve could modify the association between plasma AD-related biomarkers and cognitive decline, such that elevated plasma NfL and GFAP were associated with an accelerated decline in processing speed only among individuals with lower cognitive reserve, but not among those with higher cognitive reserve. This evidence concerns the gene GFAP and Alzheimer disease.